BioSpace News Archive

Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the appointment of Andrew Partridge as executive vice president and chief commercial officer, effective today. Mr. Partridge has more than 20 years of global pharmaceutical sales and marketing experience leading more than 20 commercial launches across multiple indications, including

Renalytix AI plc (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, today announced the commencement of an underwritten offering of 11,000,000 of its ordinary shares, which includes a regi

Hometa announces entry into infusion technology market by obtaining exclusive rights to manufacture and distribute the award-winning DripAssist Infusion Rate Monitor

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) a global specialty pharmaceutical company, is establishing a general grant program to support the education of African-American patients about cutaneous T-cell lymphomas (CTCL) and address racial disparities in diagnosis, treatment and outcomes. Studie

Spectroscopy® and LCGC™ , two MJH Life Sciences™ publications, are proud to announce that Lydia Neguse, a junior at California Academy of Mathematics and Science School in Carson, won the 2020 Most Outstanding Female in Chemistry or Chemical Analysis award at the Los Angeles County Science and Engineering Fair, held virtually Friday, March 20.

Hemogenyx Pharmaceuticals plc (LSE:HEMO) (“Hemogenyx Pharmaceuticals” or the “Company”) On 26 June 2020 the Company announced a Development Agreement with a global pharmaceutical company (“GlobalCo”). GlobalCo has now consented to the use of its name in the announcement, an updated version of which is shown below. Hemogenyx Pharmaceuticals plc is pleased to announce that it has signed a Biological Investigation and Materi

Transparency Life Sciences (TLS) today announced the addition of Craig Lipset to the advisory board.

Major League Lacrosse (MLL) today announced a partnership with Biodesix, Inc., whereby Biodesix will be the exclusive provider of COVID-19 testing for the upcoming 2020 MLL season.

Professor Cheng Chao-Min of the Institute of Biomedical Engineering at National Tsing Hua University has recently developed a new covid-19 rapid test kit which allows the physician to provide timely treatment to high-risk patients, thereby making more efficient use of such critical equipment as respirators.

Immunomedics, Inc.(NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today announced an extension of its current clinical collaboration with Roche to evaluate Trodelvy, Immunomedics’ anti-Trop-2 ADC, in combination with Tecentriq,